Trial Profile
Efficacy of combination of liraglutide and dapagliflozin in patients with type 2 diabetes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Jul 2017
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary) ; Liraglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 13 Jun 2017 Results presented at the 77th Annual Scientific Sessions of the American Diabetes Association
- 19 Oct 2016 New trial record
- 16 Sep 2016 Results (n=54) presented at the 52nd Annual Meeting of the European Association for the Study of Diabetes